MedTrace Logo

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

NCT01832480 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 623

Last updated 2019-02-12

Study results available
· View outcomes & findings →

Summary

The overall goal of this project is to determine the influence of patient treatment and host factors on repeat Trichomonas vaginalis (TV) infections among HIV-negative women

Conditions

  • Vaginitis Trichomonal or Due to Trichomonas

Interventions

DRUG

MTZ 500 mg twice daily x 7 days

MTZ 500 mg twice daily x 7 days

DRUG

MTZ 2 g

MTZ 2 g

Sponsors & Collaborators

  • Tulane University Health Sciences Center

    lead OTHER

Principal Investigators

  • Patricia Kissinger, MD · Tulane Univeristy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-06
Primary Completion
2017-06-05
Completion
2017-06-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01832480 on ClinicalTrials.gov